PT - JOURNAL ARTICLE AU - Ndiaye, Yaye Die AU - Wong, Wesley AU - Thwing, Julie AU - Schaffner, Stephen S AU - Tine, Abdoulaye AU - Diallo, Mamadou Alpha AU - Deme, Awa AU - Sy, Mouhammad AU - Bei, Amy K AU - Thiaw, Alphonse B AU - Daniels, Rachel AU - Ndiaye, Tolla AU - Gaye, Amy AU - Ndiaye, Ibrahima Mbaye AU - Toure, Mariama AU - Gadiaga, Nogaye AU - Sene, Aita AU - Sow, Djiby AU - Garba, Mamane N. AU - Yade, Mamadou Samba AU - Dieye, Baba AU - Diongue, Khadim AU - Zoumarou, Daba AU - Ndiaye, Aliou AU - Gomis, Jules AU - Fall, Fatou Ba AU - Ndiop, Medoune AU - Diallo, Ibrahima AU - Sene, Doudou AU - Macinnis, Bronwyn AU - Seck, Mame Cheikh AU - Ndiaye, Mouhamadou AU - Badiane, Aida S. AU - Hartl, Daniel L. AU - Volkman, Sarah K. AU - Wirth, Dyann F. AU - Ndiaye, Daouda TI - Two decades of molecular surveillance in Senegal reveal changes in known drug resistance mutations associated with historical drug use and seasonal malaria chemoprevention AID - 10.1101/2023.04.24.23288820 DP - 2023 Jan 01 TA - medRxiv PG - 2023.04.24.23288820 4099 - http://medrxiv.org/content/early/2023/04/26/2023.04.24.23288820.short 4100 - http://medrxiv.org/content/early/2023/04/26/2023.04.24.23288820.full AB - Drug resistance in Plasmodium falciparum is a major threat to malaria control efforts. We analyzed data from two decades (2000-2020) of continuous molecular surveillance of P. falciparum parasite strains in Senegal to determine how historical changes in drug administration policy may have affected parasite evolution. We profiled several known drug resistance markers and their surrounding haplotypes using a combination of single nucleotide polymorphism (SNP) molecular surveillance and whole-genome sequence (WGS) based population genomics. We observed rapid changes in drug resistance markers associated with the withdrawal of chloroquine and introduction of sulfadoxine-pyrimethamine in 2003. We also observed a rapid increase in Pfcrt K76T and decline in Pfdhps A437G starting in 2014, which we hypothesize may reflect changes in resistance or fitness caused by seasonal malaria chemoprevention (SMC). Parasite populations evolve rapidly in response to drug use, and SMC preventive efficacy should be closely monitored.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialPACTR 202003802011316Funding StatementThe work was supported by the NIH/ICEMR, International Centre of Excellence for Malaria Research, west Africa (U19AI089696) and the Bill and Melinda Gates Foundation (0PP1200177).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by the Ministry of Health and Social Action in Senegal (Protocol SEN14/49) and the Institutional Review Board at Harvard TH Chan School of Public Health (CR-16330-07).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors